Nyrada Inc. (ASX: NYR) Webcast Replay
Nyrada Inc. (ASX: NYR) is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases..
As a part of our ‘Meet the CEOs’ series, CEO James Bonnar provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 24th June 2020 at 12pm (AEST).
Join the next Meet the CEOs webcastFEATURE SPEAKERS
James Bonnar
Chief Executive Officer
Nyrada Inc. (ASX: NYR) is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases. The Company has two main programs, each targeting market sectors of significant size and considerable unmet clinical need.
